Tumor-promoting actions for P2X7 receptor have been described for mesothelioma [78], pancreatic carcinoma [105, 111], ovarian carcinoma [79], osteosarcoma cells [106], and neuroblastoma cells [109]. Here, P2RX7 is linked to neuroblastoma.